Anthelmintic drug discovery: target identification, screening methods and the role of open science. (2020)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3762/bjoc.16.105
PubMed Identifier: 32550933
Publication URI: http://europepmc.org/abstract/MED/32550933
Type: Journal Article/Review
Volume: 16
Parent Publication: Beilstein journal of organic chemistry
ISSN: 1860-5397